Literature DB >> 2402490

Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.

D M Weiner1, A I Levey, M R Brann.   

Abstract

Within the basal ganglia, acetylcholine and dopamine play a central role in the extrapyramidal control of motor function. The physiologic effects of these neurotransmitters are mediated by a diversity of receptor subtypes, several of which have now been cloned. Muscarinic acetylcholine receptors are encoded by five genes (m1-m5), and of the two known dopamine receptor subtypes (D1 and D2) the D2 receptor gene has been characterized. To gain insight into the physiological roles of each of these receptor subtypes, we prepared oligodeoxynucleotide probes to localize receptor subtype mRNAs within the rat striatum and substantia nigra by in situ hybridization histochemistry. Within the striatum, three muscarinic (m1, m2, m4) receptor mRNAs and the D2 receptor mRNA were detected. The m1 mRNA was expressed in most neurons (greater than 80%); the m2 mRNA, in neurons which were both very large and rare; and the m4 and D2 mRNAs, in 40-50% of the neurons, one-third of which express both mRNAs. Within the substantia nigra, pars compacta, only the m5 and D2 mRNAs were detected, and most neurons expressed both mRNAs. These data provide anatomical evidence for the identity of the receptor subtypes which mediate the diverse effects of muscarinic and dopaminergic drugs on basal ganglia function.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2402490      PMCID: PMC54680          DOI: 10.1073/pnas.87.18.7050

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Primary structure of rat cardiac beta-adrenergic and muscarinic cholinergic receptors obtained by automated DNA sequence analysis: further evidence for a multigene family.

Authors:  J Gocayne; D A Robinson; M G FitzGerald; F Z Chung; A R Kerlavage; K U Lentes; J Lai; C D Wang; C M Fraser; J C Venter
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Cholinergic-anticholinergic antagonism in parkinsonism.

Authors:  R C Duvoisin
Journal:  Arch Neurol       Date:  1967-08

Review 4.  Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis.

Authors:  M F Chesselet
Journal:  Neuroscience       Date:  1984-06       Impact factor: 3.590

5.  The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system.

Authors:  C Pycock; J Milson; D Tarsy; C D Marsden
Journal:  Neuropharmacology       Date:  1978-03       Impact factor: 5.250

6.  Further evidence for the involvement of D2, but not D1 dopamine receptors in dopaminergic control of striatal cholinergic transmission.

Authors:  B Scatton
Journal:  Life Sci       Date:  1982-12-20       Impact factor: 5.037

7.  The afferent and efferent connections of the feline nucleus tegmenti pedunculopontinus, pars compacta.

Authors:  S M Edley; A M Graybiel
Journal:  J Comp Neurol       Date:  1983-06-20       Impact factor: 3.215

8.  Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain.

Authors:  M Raiteri; R Leardi; M Marchi
Journal:  J Pharmacol Exp Ther       Date:  1984-01       Impact factor: 4.030

9.  Co-localization of acetylcholinesterase and choline acetyltransferase in the rat cerebrum.

Authors:  A I Levey; B H Wainer; E J Mufson; M M Mesulam
Journal:  Neuroscience       Date:  1983-05       Impact factor: 3.590

10.  Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat.

Authors:  M F Giorguieff; M L Le Floc'h; J Glowinski; M J Besson
Journal:  J Pharmacol Exp Ther       Date:  1977-03       Impact factor: 4.030

View more
  122 in total

1.  Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice.

Authors:  J Gomeza; L Zhang; E Kostenis; C Felder; F Bymaster; J Brodkin; H Shannon; B Xia; C Deng; J Wess
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  Cholinergic modulation of neostriatal output: a functional antagonism between different types of muscarinic receptors.

Authors:  E Galarraga; S Hernández-López; A Reyes; I Miranda; F Bermudez-Rattoni; C Vilchis; J Bargas
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

3.  Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice.

Authors:  M Yamada; K G Lamping; A Duttaroy; W Zhang; Y Cui; F P Bymaster; D L McKinzie; C C Felder; C X Deng; F M Faraci; J Wess
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

4.  Identification and characterization of muscarinic acetylcholine receptor subtypes expressed in human skin melanocytes.

Authors:  R Buchli; A Ndoye; J Arredondo; R J Webber; S A Grando
Journal:  Mol Cell Biochem       Date:  2001-12       Impact factor: 3.396

5.  Effect of neuropeptide-EI on the binding of [3H]SCH 23390 to the dopamine D1 receptor in rat striatal membranes.

Authors:  M S Sanchez; N A Salvatierra; G Vettori; M E Celis
Journal:  Neurochem Res       Date:  2001-05       Impact factor: 3.996

6.  Involvement of the parafascicular nucleus of the thalamus and the cholinoreactive system of the neostriatum in controlling a food-procuring reflex in rats at different stages of learning.

Authors:  D L Tikhonravov
Journal:  Neurosci Behav Physiol       Date:  2000 Jul-Aug

Review 7.  Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system.

Authors:  Frank P Bymaster; David L McKinzie; Christian C Felder; Jürgen Wess
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

8.  Presynaptic dopamine D2 and muscarine M3 receptors inhibit excitatory and inhibitory transmission to rat subthalamic neurones in vitro.

Authors:  K Z Shen; S W Johnson
Journal:  J Physiol       Date:  2000-06-01       Impact factor: 5.182

9.  Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments.

Authors:  Kazuko Sakata; Abigail E Overacre
Journal:  J Neurochem       Date:  2017-08-16       Impact factor: 5.372

10.  A comparison of behaviour following stimulation of the anterior substantia nigra by direct cholinergic agonists and anticholinesterases.

Authors:  G C Parker; W L Inglis; P Winn
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.